1 - 10 out of 10Page size: 10
  1. 2022

  2. Evaluation of the feasibility of screening for paediatric non-alcoholic fatty liver disease

    Amsterdam Paediatric Obesity Collaboration, Dec 2022, In: Acta paediatrica (Oslo, Norway. 111, 12, p. 2408-2415 8 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. 2021

  4. Diagnostic accuracy of fibrosis tests in children with non-alcoholic fatty liver disease: A systematic review

    Draijer, L. G., van Oosterhout, J. P. M., Vali, Y., Zwetsloot, S., van der Lee, J. H., van Etten-Jamaludin, F. S., Chegary, M., Benninga, M. A. & Koot, B. G. P., Sep 2021, In: Liver international. 41, 9, p. 2087-2100 14 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. 2020

  6. Survey on screening for paediatric non-alcoholic fatty liver disease in clinical practice in Dutch hospitals

    Draijer, L. G., Haggenburg, S., Benninga, M. A., Chegary, M. & Koot, B. G. P., 1 Nov 2020, In: Acta paediatrica (Oslo, Norway. 109, 11, p. 2388-2393 6 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. Hyperinsulinism in a patient with a Zellweger Spectrum Disorder and a 16p11.2 deletion syndrome

    Hoytema van Konijnenburg, E. M. M., Luirink, I. K., Schagen, S. E. E., Engelen, M., Berendse, K., Poll-The, B. T. & Chegary, M., Jun 2020, In: Molecular genetics and metabolism reports. 23, 100590.

    Research output: Contribution to journal › Article › Academic › peer-review

  8. 2019

  9. Successful Treatment of Hereditary Folate Malabsorption With Intramuscular Folinic Acid

    Lubout, C. M. A., Goorden, S. M. I., van den Hurk, K., Jaeger, B., Jager, N. G. L., van Koningsbruggen, S., Chegary, M. & van Karnebeek, C. D. M., Jan 2019, In: Pediatric neurology. 102, p. 62-66

    Research output: Contribution to journal › Article › Academic › peer-review

  10. 2012

  11. Ethnic diversity outpatient clinic in paediatrics

    Dahhan, N., Meijssen, D., Chegary, M., Bosman, D. & Wolf, B., 2012, In: BMC health services research. 12, p. 12

    Research output: Contribution to journal › Article › Academic › peer-review

  12. 2009

  13. Mitochondrial long chain fatty acid beta-oxidation in man and mouse

    Chegary, M., Brinke, H. T., Ruiter, J. P. N., Wijburg, F. A., Stoll, M. S. K., Minkler, P. E., van Weeghel, M., Schulz, H., Hoppel, C. L., Wanders, R. J. A. & Houten, S. M., 2009, In: BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. 1791, 8, p. 806-815

    Research output: Contribution to journal › Article › Academic › peer-review

  14. Pathophysiology of mitochondrial fatty acid oxidation

    Chegary, M., 2009, 130 p.

    Research output: Thesis › Phd-Thesis - Research and graduation internal

  15. Pyruvate dehydrogenase kinase 4 expression is synergistically induced by AMP-activated protein kinase and fatty acids

    Houten, S. M., Chegary, M., te Brinke, H., Wijnen, W. J., Glatz, J. F. C., Luiken, J. J. F. P., Wijburg, F. A. & Wanders, R. J. A., 2009, In: Cellular and molecular life sciences. 66, 7, p. 1283-1294

    Research output: Contribution to journal › Article › Academic › peer-review

  16. 2008

  17. Characterization of L-aminocarnitine, an inhibitor of fatty acid oxidation

    Chegary, M., te Brinke, H., Doolaard, M., Ijlst, L., Wijburg, F. A., Wanders, R. J. A. & Houten, S. M., 2008, In: Molecular genetics and metabolism. 93, 4, p. 403-410

    Research output: Contribution to journal › Article › Academic › peer-review

ID: 46638